Biotricity Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Biotricity
BTCY Stock  USD 0.28  0.02  6.67%   
Biotricity's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Biotricity's valuation are provided below:
Gross Profit
11.3 M
Profit Margin
(0.37)
Market Capitalization
14.2 M
Enterprise Value Revenue
2.3896
Revenue
14.5 M
We have found one hundred twenty available fundamental signals for Biotricity, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Biotricity prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 59.1 M in 2026. Enterprise Value is likely to rise to about 67.5 M in 2026

Biotricity Total Revenue

16.65 Million

Check Biotricity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biotricity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.1 K, Interest Expense of 6.3 M or Selling General Administrative of 9.8 M, as well as many indicators such as Price To Sales Ratio of 0.58, Dividend Yield of 0.0035 or Days Sales Outstanding of 141. Biotricity financial statements analysis is a perfect complement when working with Biotricity Valuation or Volatility modules.
  
Build AI portfolio with Biotricity Stock
Check out the analysis of Biotricity Correlation against competitors.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.

Biotricity Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.1 M6.5 M3.3 M
Slightly volatile
Short and Long Term Debt Total31.5 M30 M9.3 M
Slightly volatile
Other Current Liabilities4.2 M4 M1.6 M
Slightly volatile
Total Current Liabilities24.9 M23.7 M7.8 M
Slightly volatile
Accounts Payable5.6 M5.3 M1.8 M
Slightly volatile
Cash398.9 K419.9 K1.3 M
Pretty Stable
Cash And Short Term Investments398.9 K419.9 K1.3 M
Pretty Stable
Net Receivables3.3 M3.1 M999.9 K
Slightly volatile
Common Stock Total Equity27.8 K44.9 K26.2 K
Slightly volatile
Common Stock Shares Outstanding26 M24.8 M9.1 M
Slightly volatile
Liabilities And Stockholders Equity4.1 M6.5 M3.3 M
Slightly volatile
Non Current Liabilities Total18.1 M17.3 M5.9 M
Slightly volatile
Other Stockholder Equity129.5 M123.3 M48.8 M
Slightly volatile
Total Liabilities43.1 M41 M13.4 M
Slightly volatile
Total Current Assets3.5 M5.3 M2.9 M
Slightly volatile
Short Term Debt15.2 M14.4 M4.3 M
Slightly volatile
Common Stock32.9 K30.2 K25.6 K
Slightly volatile
Non Current Assets Total683.5 K1.2 M483.2 K
Slightly volatile
Non Currrent Assets Other74.4 K125.7 K61.2 K
Slightly volatile
Other Assets1.091.1530.2 K
Slightly volatile
Short Term Investments710.7 K676.9 K255.8 K
Slightly volatile
Other Current Assets259.5 K386.9 K186.9 K
Slightly volatile
Long Term Investments26.4 K29.7 K32.4 K
Slightly volatile
Short and Long Term Debt14.5 M13.8 M4.3 M
Slightly volatile
Capital Stock2.4 M2.3 M517.6 K
Slightly volatile
Property Plant And Equipment Net965.9 K944.9 K562.3 K
Slightly volatile
Capital Lease Obligations1 M1.1 M602.4 K
Slightly volatile
Property Plant And Equipment Gross974.1 K968.1 K566.8 K
Slightly volatile
Property Plant Equipment1.5 M1.5 M634.5 K
Slightly volatile
Other Liabilities305 K317.2 K384.8 K
Slightly volatile
Long Term Debt11 M15.1 M4.7 M
Slightly volatile
Capital Surpluse45 M50.7 M55.3 M
Slightly volatile
Deferred Long Term Liabilities328 K369 K402.8 K
Slightly volatile
Preferred Stock Total Equity6.47.27.8588
Slightly volatile
Non Current Liabilities Other296.7 K333.8 K364.4 K
Slightly volatile

Biotricity Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization5.1 K5.4 K2.7 M
Very volatile
Selling General Administrative9.8 M12.5 M7.6 M
Slightly volatile
Other Operating Expenses13.3 M18.7 M10.4 M
Slightly volatile
Research Development1.9 M2.5 M1.5 M
Slightly volatile
Total Operating Expenses11.7 M15 M9.1 M
Slightly volatile
Preferred Stock And Other Adjustments769.7 K865.9 K945.2 K
Slightly volatile
Non Operating Income Net Other297.8 K335 K365.7 K
Slightly volatile

Biotricity Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Cashflows From Financing Activities1.9 M2 M2.9 M
Slightly volatile
Total Cash From Financing Activities2.1 M2.2 M4.6 M
Slightly volatile
Net Borrowings110.9 K116.7 K2.6 M
Pretty Stable
Depreciation6.5 K6.8 K313.6 K
Pretty Stable
End Period Cash Flow398.9 K419.9 K1.2 M
Pretty Stable
Change To Netincome3.4 M5.5 M3 M
Slightly volatile
Stock Based Compensation1 M1.3 M1.5 M
Slightly volatile
Begin Period Cash Flow858.8 K904 K1.3 M
Slightly volatile
Dividends Paid32.8 K34.5 K260.7 K
Very volatile
Issuance Of Capital Stock1.6 M1.7 M3.9 M
Very volatile
Cash And Cash Equivalents Changes898.1 K1 M1.1 M
Slightly volatile
Cash Flows Other Operating675.6 K760.1 K829.6 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.580.6144.502
Slightly volatile
Dividend Yield0.00350.00370.007
Pretty Stable
Days Sales Outstanding14182.75225
Slightly volatile
Average Payables216 K227.4 K1.5 M
Slightly volatile
Stock Based Compensation To Revenue0.120.1062.0795
Slightly volatile
Capex To Depreciation6.0E-46.0E-49.1042
Slightly volatile
EV To Sales2.622.7646.2821
Slightly volatile
Inventory Turnover2.272.399.2082
Slightly volatile
Days Of Inventory On Hand88.1615872.3689
Slightly volatile
Payables Turnover1.340.810.8109
Slightly volatile
Sales General And Administrative To Revenue0.860.9110.8697
Slightly volatile
Research And Ddevelopement To Revenue0.170.181.9161
Slightly volatile
Cash Per Share0.190.11270.2035
Pretty Stable
Days Payables Outstanding476599687
Slightly volatile
Income Quality0.390.37870.5077
Very volatile
Current Ratio0.490.27650.4597
Pretty Stable
Receivables Turnover3.394.572.7203
Slightly volatile
Average Receivables2.1 M2 M922 K
Slightly volatile
Revenue Per Share0.570.580.3928
Slightly volatile
Interest Debt Per Share0.220.23161.0023
Slightly volatile
Debt To Assets1.861.50992.5258
Pretty Stable
Operating Cycle262285302
Slightly volatile
Days Of Payables Outstanding476599687
Slightly volatile
Ebt Per Ebit1.171.01091.3754
Slightly volatile
Quick Ratio0.450.29710.4269
Pretty Stable
Cash Ratio0.330.23350.324
Pretty Stable
Days Of Inventory Outstanding88.1615872.3689
Slightly volatile
Days Of Sales Outstanding14182.75225
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.80.90.9841
Slightly volatile
Fixed Asset Turnover17.4419.310.5933
Slightly volatile
Debt Ratio1.861.50992.5258
Pretty Stable
Price Sales Ratio0.580.6144.502
Slightly volatile
Asset Turnover2.312.21.1587
Slightly volatile
Gross Profit Margin0.40.690.3401
Slightly volatile

Biotricity Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap59.1 M57.9 M57.6 M
Slightly volatile
Enterprise Value67.5 M58.3 M62.9 M
Pretty Stable

Biotricity Fundamental Market Drivers

Biotricity Upcoming Events

13th of February 2024
Upcoming Quarterly Report
View
4th of July 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of July 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of March 2023
Last Financial Announcement
View

About Biotricity Financial Statements

Biotricity investors use historical fundamental indicators, such as Biotricity's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biotricity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue29.1 K27.7 K
Total Revenue15.9 M16.7 M
Cost Of Revenue3.7 M3.9 M
Stock Based Compensation To Revenue 0.11  0.12 
Sales General And Administrative To Revenue 0.91  0.86 
Research And Ddevelopement To Revenue 0.18  0.17 
Revenue Per Share 0.58  0.57 
Ebit Per Revenue(0.16)(0.17)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft

Additional Tools for Biotricity Stock Analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY